0

Carlos Alberto Lobato Tapia

Universidad Politecnica Metropolitana de Puebla, Mexico

Title: In silico analysis of Aloysia triphylla compounds with potential anxiolytic activity

Abstract

Anxiety disorders, characterized by persistent worry, have a worldwide prevalence ranging from 3.8 to 25 %. The available treatments produce adverse effects in some patients. Another treatment option is to use medicinal plants with the ability to induce states of relaxation and tranquility, such is the case of Aloysia triphylla (lemon verbena). Thus, the objective of this work was to determine, in silico, the anxiolytic activity of the different compounds reported for A. triphylla and to evaluate the pharmacokinetic behavior of those compounds that result in better activities. The reported compounds were searched in Google Scholar and Pubmed, once the list was obtained, they were entered in the PASS online platform to obtain their most likely activities. Those activities related to anxiety were chosen (Treatment for phobia disorder and GABA transaminase inhibitor) and these compounds were evaluated for their pharmacokinetic behavior in the ADMET Lab 2.0 server. The results show that thirty-seven compounds had possible anxiolytic activity, of which seven resulted with a probability above 90% and with (estimated) pharmacokinetic parameters suitable for future administrations in preclinical and clinical trials.

Biography

Carlos Alberto Lobato Tapia has a PhD in Biomedical Sciences, his line of research focuses on the search for bioactive compounds from plants, from obtaining extracts to evaluating activities through cheminformatics tools. He has more than 8 years of teaching experience. Likewise, he has participated as a reviewer for several international magazines.